J. Thompson

R. Saw, C. Young, J. Thompson, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis☆

P. Pollock, G. Mann, N. Hayward, 2015, EBioMedicine.

Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases

R. Saw, J. Stretch, S. Ch’ng, 2020, Melanoma research.

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

M. Gore, C. Fisher, P. Hersey, 2020, Journal for ImmunoTherapy of Cancer.

Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients

R. Scolyer, T. Chua, B. McCaughan, 2012, Annals of Surgical Oncology.

Inter‐ and intrapatient heterogeneity of indoleamine 2,3‐dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment

J. Madore, J. Wilmott, R. Scolyer, 2019, Histopathology.

The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma

D. Elashoff, A. Testori, Douglas B. Johnson, 2017, Annals of Surgical Oncology.

DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.

J. Wilmott, R. Scolyer, D. Morton, 2014, Neuro-oncology.

BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.

Stephen B. Fox, S. Prakash, K. Shannon, 2021, Pathology.

Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

C. Begg, I. Ostrovnaya, R. Scolyer, 2009, The Journal of investigative dermatology.

Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease—Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004

J. Jabbour, R. Cumming, R. Scolyer, 2007, Annals of surgical oncology.

Cytologic features of metastatic and recurrent melanoma in patients with primary cutaneous desmoplastic melanoma.

R. Scolyer, R. Murali, G. Watson, 2008, American journal of clinical pathology.

Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence: A Clinicopathologic Study of 1152 Patients Undergoing Sentinel Lymph Node Biopsy

R. Scolyer, S. McCarthy, Ling-Xi L. Li, 2003, The American journal of surgical pathology.

Association Between Melanoma Detected During Routine Skin Checks and Mortality.

S. Menzies, H. Soyer, J. Aitken, 2021, JAMA dermatology.

Evidence-based clinical practice guidelines on the use of sentinel lymph node biopsy in melanoma.

V. Sondak, J. Gershenwald, S. Wong, 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Sentinel lymph node biopsy for melanoma: critical assessment at its twentieth anniversary.

M. Ross, J. Gershenwald, J. Thompson, 2011, Surgical oncology clinics of North America.

Sentinel Node Metastasis From Thin Melanomas With Vertical Growth Phase

H. Shaw, J. Thompson, 2000, Annals of Surgical Oncology.

Is Sentinel Lymph Node Biopsy Appropriate in Patients With Thin Melanomas: Too Early To Tell?

H. Shaw, J. Thompson, 2006, Annals of Surgical Oncology.

Sentinel node biopsy and standard of care for melanoma.

V. Sondak, M. Ross, J. Gershenwald, 2009, Journal of the American Academy of Dermatology.

Frequency of nonsentinel lymph node metastasis in melanoma

H. Shaw, J. Thompson, 2002, Annals of Surgical Oncology.

The impact of socioeconomic status on melanoma clinical trial participation: an observational cohort study from Australia.

L. Haydu, R. Morton, Joshua L Lee, 2014, Melanoma management.

Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts

K. Nielsen, R. Scolyer, C. Ingvar, 2018, Journal of surgical oncology.

Effects of Long‐term 4‐Aminopyridine Therapy on Glucose Tolerance and Glucokinetics in Patients with Spinal Cord Injury

J. Segal, J. Tayek, J. Thompson, 2007, Pharmacotherapy.

Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value

A. Nicolas, S. Roman-Roman, J. Wilmott, 2020, The journal of pathology. Clinical research.

End‐stage renal failure in children: 16 years' experience at one Australian centre

E. Hodson, J. Knight, L. Roy, 1990, The Medical journal of Australia.

Genomic Classification of Cutaneous Melanoma

Steven J. M. Jones, Martin L. Miller, Jared C Malke, 2015, Cell.

Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.

A. Einstein, R. Saw, S. Lord, 2021, Annals of Surgical Oncology.

Targeted alpha therapy for cancer

Yong Li, J. Kearsley, B. Allen, 2004, Physics in medicine and biology.

BAP1 expression in cutaneous melanoma: a pilot study.

H. Al-Ahmadie, J. Wilmott, R. Scolyer, 2013, Pathology.

Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand.

G. Screaton, R. Scolyer, P. Hersey, 2006, Human pathology.

Histological expression of tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) in human primary melanoma

R. Scolyer, P. Hersey, L. Bron, 2004, Pathology.

Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1–2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center

K. Shannon, R. Scolyer, L. Haydu, 2016, Annals of Surgical Oncology.

Textbook of melanoma

D. Morton, B. Kroon, J. Thompson, 2004 .

Chapter 35 – Cancer in Dialysis and Kidney Transplant Patients

A. Webster, J. Thompson, 2014 .

Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy.

R. Kefford, B. Nankivell, C. Liddle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased expression of apoptotic markers in melanoma

R. Scolyer, M. Slater, A. Gidley-Baird, 2003, Melanoma research.

Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis.

J. Wilmott, R. Scolyer, G. Long, 2021, Pathology.

Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma

C. O'brien, M. Quinn, W. McCarthy, 1994, Melanoma research.

Survival in patients with desmoplastic melanoma.

R. Scolyer, M. Quinn, H. Shaw, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma.

John E. Mullinax, R. Gonzalez, J. Zager, 2017, Journal of the American College of Surgeons.

Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients

J. Wilmott, R. Scolyer, G. Long, 2017, Modern Pathology.

Porphyry deposits; characteristics and origin of hypogene features

M. Barton, J. Richards, J. Dilles, 2005 .

Abstract 5671: Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project

Brett J. Kennedy, Lisa M Haley, Mingchao Xie, 2020 .

MSLT-I—response of clinical trial investigators

A. Cochran, M. Faries, J. Thompson, 2014, Nature Reviews Clinical Oncology.

1220PDPhase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

K. Shannon, R. Scolyer, R. Kefford, 2017 .

Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial.

Marisa C. Jenkins, L. Irwig, R. Scolyer, 2021, JAMA dermatology.

Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery.

S. Nishida, D. Levi, J. Madariaga, 2003, Journal of the American College of Surgeons.

The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma

A. Einstein, S. Lo, R. Saw, 2022, Annals of Surgical Oncology.

New Australian melanoma management guidelines: the patient perspective

Alison Button-Sloan, J. Thompson, 2020, The Medical journal of Australia.

Has the melanoma information tsunami become a maelstrom?

A. Menzies, J. Thompson, 2017, Melanoma management.

The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma

R. Read, P. Stalley, J. Thompson, 2015, Annals of Surgical Oncology.

Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.

R. Scolyer, S. McCarthy, R. Saw, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study

V. Sondak, R. Scolyer, S. Lo, 2022, Annals of Surgical Oncology.

The prognostic significance of microsatellites in cutaneous melanoma

R. Scolyer, L. Haydu, R. Karim, 2020, Modern Pathology.

Primary anorectal melanoma: clinical, immunohistology and DNA analysis of 43 cases.

J. Wilmott, R. Scolyer, G. Long, 2019, Pathology.

Identification of new prognostic biomarkers for Stage III metastatic melanoma patients

G. Mann, R. Scolyer, H. Kakavand, 2013, Oncoimmunology.

Isolated Limb Infusion for Melanoma

P. Kam, J. Zager, P. Lindnér, 2018, Cutaneous Melanoma.

Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma

K. Shannon, R. Scolyer, L. Haydu, 2012, Annals of surgery.

Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy for melanoma: Incidence varies with primary tumor site

R. Uren, R. Howman-Giles, J. Thompson, 1998, Annals of Surgical Oncology.

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.

R. Fisher, K. Shannon, R. Scolyer, 2015, The Lancet. Oncology.

Locally advanced melanoma

C. O'brien, G. Stevens, M. Quinn, 2020, Cancer.

Biopsy of the Sentinel Lymph Node

V. Sondak, A. Cochran, S. Wong, 2020, Cutaneous Melanoma.

Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.

R. Scolyer, L. Haydu, G. Long, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice

S. Lo, A. Hong, G. Fogarty, 2016, BMC Cancer.

Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communication.

H. Soyer, R. Scolyer, B. Coventry, 2019, Australian journal of general practice.

TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.

R. Scolyer, K. Tchou-Wong, F. Martiniuk, 2010, Journal of drugs in dermatology : JDD.

Melanoma of the urogenital tract

M. Henderson, J. Thompson, 2003 .

Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.

P. V. van Diest, R. Scolyer, A. Witkamp, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma

R. Scolyer, C. Cooper, R. Murali, 2010, Annals of Surgical Oncology.

Cellular blue naevus involving the urinary bladder.

G. Mann, G. Pupo, R. Scolyer, 2012, Pathology.

Radiofrequency ablation in metastatic melanoma

A. Shashank, D. Morris, M. Shehata, 2014, Journal of surgical oncology.

Interleukin-10 regulates arterial pressure in early primate pregnancy.

J. Rasko, J. Horvath, A. Hennessy, 2005, Cytokine.

Management of pigmented skin lesions in childhood and adolescence.

J. Thompson, Erica B Friedman, Richard A Scolyer, 2019, Australian journal of general practice.

Cutaneous melanoma in childhood: Incidence and prognosis

W. McCarthy, H. Shaw, G. Milton, 1997, The Australasian journal of dermatology.

Futility of imaging to stage melanoma patients with a positive sentinel lymph node

O. Nieweg, R. Read, L. Emmett, 2017, Melanoma research.

Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol

R. Turner, John F. Thompson, R. Saw, 2020, BMJ Open.

Predicting response to IL-2 therapy for metastatic melanoma

A. Guminski, J. Thompson, 2009, Expert review of anticancer therapy.

Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma

R. Scolyer, C. Harper, Soon C. Lee, 2004, Melanoma research.

Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial

H. Soyer, L. Irwig, R. Scolyer, 2021, Trials.

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.

R. Fisher, K. Shannon, R. Scolyer, 2012, The Lancet. Oncology.

Instructions for authors (www.scielo.br/spmj)

M. Lens, C. Balch, D. Berg, 2009, The Cochrane database of systematic reviews.

A highly recurrent RPS27 5'UTR mutation in melanoma

K. Dutton-Regester, G. Mann, N. Hayward, 2014, Oncotarget.

Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma

R. Uren, D. Chung, R. Howman-Giles, 2011, Journal of surgical oncology.

Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes.

P. V. van Diest, K. Shannon, R. Scolyer, 2022, European journal of cancer.

Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.

P. V. van Diest, K. Shannon, R. Scolyer, 2022, European journal of cancer.

Lymphoscintigraphy in Patients with Melanoma

O. Nieweg, R. Uren, J. Thompson, 2018, Cutaneous Melanoma.

Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management

R. Scolyer, S. Lo, R. Vilain, 2016, Annals of Surgical Oncology.

Developments in surgical oncology — past, present and future trends

W. McCarthy, D. Storey, F. Niesche, 1991, The Medical journal of Australia.

The Optimum Excision Margin and Regional Node Management for Primary Cutaneous T3 Melanomas (2–4 mm in Thickness): A Retrospective Study of 1587 Patients Treated at a Single Center

K. Shannon, R. Scolyer, L. Haydu, 2014, Annals of surgery.

First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality

R. Scolyer, H. Dhillon, A. Hong, 2015, BMC Research Notes.

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

L. Haydu, A. Hong, G. Fogarty, 2014, BMC Research Notes.

Treatment of in-transit melanoma metastases using intralesional PV-10

S. Lo, A. Spillane, J. Stretch, 2021, Melanoma research.

The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma

J. Zager, G. Beasley, J. Thompson, 2019, Annals of Surgical Oncology.

The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma.

R. Uren, D. Chung, R. Howman-Giles, 2006, Surgical oncology clinics of North America.

Intestinal and Multivisceral Transplantation

A. Tzakis, A. Pinna, P. Ruiz, 2002, World Journal of Surgery.

Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma

R. Scolyer, L. Zhuang, S. McCarthy, 2004, Pathology.

Anatomic position determines oncogenic specificity in melanoma

Joshua M. Weiss, R. White, B. Taylor, 2020, Nature.

Subungual melanoma of the hand.

Jeremy S. Bond, R. Scolyer, L. Haydu, 1996, The Journal of hand surgery.

Subungual Melanoma of the Hand

Jeremy S. Bond, R. Scolyer, L. Haydu, 2018, Annals of Surgical Oncology.

Current indications for intestinal transplantation

Tomoaki Kato, N. Mittal, J. Thompson, 2000 .

Patients' perspectives of long-term follow-up for localised cutaneous melanoma.

L. Irwig, L. Rychetnik, K. McCaffery, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Chapter 33 – Cancer in Dialysis and Renal Transplant Patients

J. Thompson, P. Mohacsi, 2008 .

Genetic and clinico-pathologic analysis of metastatic uveal melanoma

D. Schadendorf, B. Schilling, R. Scolyer, 2014, Modern Pathology.

Contamination and decontamination of Doppler probes.

E. Whitehead, D. R. Lewis, J. Thompson, 2006, Annals of the Royal College of Surgeons of England.

Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma.

M. Millward, M. Kohonen-Corish, W. Cooper, 2006, The Journal of investigative dermatology.

A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: The use of monoclonal antibodies and double immunolabeling

G. Bishop, B. Hall, G. McCaughan, 1990, Hepatology.

Effect of Acute Normovolemic Hemodilution on Blood Coagulation

J. Locke-Edmunds, R. Baird, P. Lamont, 1994 .

Extended experience and modifications in the design and concepts of the keystone design island flap.

J. Stretch, M. Moncrieff, J. Thompson, 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Keystone Flap Reconstruction of Primary Melanoma Excision Defects of the Leg—The End of the Skin Graft?

K. Shannon, John F. Thompson, R. Saw, 2008, Annals of Surgical Oncology.

Free flap reconstruction for melanoma of the head and neck: indications and outcomes.

Jonathan R. Clark, C. O'brien, K. Shannon, 2010, Journal of Plastic, Reconstructive & Aesthetic Surgery.

Final version of 2009 AJCC melanoma staging and classification.

Jeffrey E Gershenwald, Merrick I Ross, Charles M Balch, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The history of sentinel lymph node biopsy.

O. Nieweg, R. Uren, J. Thompson, 2015, Cancer journal.

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

R. Elashoff, A. Cochran, D. Morton, 2014, The New England journal of medicine.

False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy

K. Shannon, R. Scolyer, M. Quinn, 2009, Melanoma research.

Lymphatic mapping in management of patients with primary cutaneous melanoma.

John F. Thompson, R. Uren, J. Thompson, 2005, The Lancet. Oncology.

The history and future of melanoma staging

R. Scolyer, P. Hersey, H. Shaw, 2004, Journal of surgical oncology.

Aversion to xenotransplantation

S. Quine, J. Thompson, P. Mohacsi, 1995, Nature.

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

G. Mann, R. Scolyer, L. Haydu, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma.

R. Scolyer, R. Bourne, C. Mountford, 2005, European journal of radiology.

Spiritual Maturity: An Exploratory Study and Model for Social Work Practice

David S. Derezotes, J. Thompson, Au-Deane S. Cowley, 2008 .

Treatment of Refractory Chromomycosis by Isolated Limb Infusion with Melphalan and Actinomycin D

D. Damian, R. Barnetson, J. Thompson, 2006, Journal of cutaneous medicine and surgery.

Subungual Melanoma: A Study of 124 Cases Highlighting Features of Early Lesions, Potential Pitfalls in Diagnosis, and Guidelines for Histologic Reporting

R. Scolyer, S. McCarthy, J. Stretch, 2007, The American journal of surgical pathology.

Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma

Abraham J. Khorasani, L. Zon, C. Ceol, 2012, Cell.

Managing in-transit melanoma metastases in the new era of effective systemic therapies for melanoma

R. Read, J. Thompson, 2019, Expert review of clinical pharmacology.

Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy

R. Scolyer, John F. Thompson, M. Quinn, 2008, Annals of Surgical Oncology.

Margins of excision and prognostic factors for cutaneous eyelid melanomas.

K. Shannon, Jeremy S. Bond, R. Scolyer, 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Sentinel-node biopsy or nodal observation in melanoma.

R. Elashoff, A. Cochran, D. Morton, 2006, The New England journal of medicine.

Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma

A. Gesierich, R. Elashoff, R. Dummer, 2017, The New England journal of medicine.

Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial

R. Elashoff, A. Cochran, D. Morton, 2005, Annals of surgery.

The Unpredictability of Lymphatic Drainage from the Ear in Melanoma Patients, and Its Implications for Management

K. Shannon, L. Haydu, J. Stretch, 2013, Annals of Surgical Oncology.

Lower Lip Reconstruction Revisited - Technical Solutions to Prevent Oral Incontinence and Maximize Vermilion Anterior Projection.

R. Saw, S. Ch’ng, J. Thompson, 2020, Plastic and reconstructive surgery.

Reconstruction after wide excision of primary cutaneous melanomas: part I-the head and neck.

J. Stretch, M. Quinn, M. Moncrieff, 2009, The Lancet. Oncology.

Desmoplastic and desmoplastic neurotropic melanoma

C. O'brien, A. Coates, J. Thompson, 1998, Cancer.

Local Melanoma Recurrence, Satellitosis, and In-transit Metastasis: Incidence, Outcomes, and Selection of Treatment Options

M. Ross, N. Mozzillo, J. Thompson, 2019, Cutaneous Melanoma.

Fine-needle biopsy as a diagnostic technique for metastatic melanoma.

R. Scolyer, R. Murali, J. Thompson, 2008, Expert opinion on medical diagnostics.

Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.

S. Haferkamp, W. Peitsch, J. Becker, 2011, The Journal of investigative dermatology.

Radiation in the Management of Primary and Regional Merkel Cell Carcinoma

G. Hruby, J. Thompson, 2010 .

Patterns of lymphatic drainage from the skin in patients with melanoma.

John F. Thompson, R. Uren, R. Howman-Giles, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma

M. Mihm, B. Hesse, R. Scolyer, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Epitrochlear lymph nodes as a site of melanoma metastasis

J. Thompson, R. Uren, R. Howman-Giles, 1998, Annals of Surgical Oncology.

Cancer in Dialysis and Transplant Patients

A. Webster, B. Rosales, J. Thompson, 2019, Kidney Transplantation - Principles and Practice.

Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls

R. Scolyer, C. Cooper, John F. Thompson, 2010, Melanoma research.

Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna

R. Scolyer, C. Shiau, J. Thompson, 2013 .

Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades.

G. Stevens, A. Zacest, W. McCarthy, 2002, Journal of neurosurgery.

The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population‐based data on diagnosis and management

S. Menzies, G. Mann, R. Scolyer, 2018, The Australasian journal of dermatology.

Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna

H. Soyer, R. Scolyer, P. Guitera, 2019, Dermatology.

Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care

R. Scolyer, G. Long, John F. Thompson, 2011, Molecular oncology.

Atypical fibroxanthoma: differential diagnosis from other sarcomatoid skin lesions

R. Scolyer, S. McCarthy, R. Murali, 2010 .

Isolated Imunohistochemistry-positive Cells Without Morphologic Characteristics of Melanoma Should Not Result in Designation as a Positive Sentinel Lymph Node According to the AJCC 8th Edition Staging System.

R. Scolyer, J. Gershenwald, J. Thompson, 2019, The American journal of surgical pathology.

Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.

Richard A Scolyer, R. Scolyer, S. McCarthy, 2010, Archives of pathology & laboratory medicine.

Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas

J. Wilmott, R. Scolyer, D. Coit, 2009, The American journal of surgical pathology.

Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment.

R. Scolyer, R. Murali, J. Thompson, 2008, Future oncology.

Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy

M. Ross, J. Kirkwood, C. Balch, 2001, Annals of Surgical Oncology.

Surgical management of the neck in patients with metastatic melanoma in parotid lymph nodes

K. Shannon, R. Scolyer, S. Ch’ng, 2019, Journal of surgical oncology.

Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma

V. Gebski, C. O'brien, G. Stevens, 1997, Head & neck.

Spitz naevus: diagnostic problems and their management implications.

R. Scolyer, J. Dahlstrom, Sanjiv K. Jain, 2004, Pathology.

Desmoplastic neurotropic melanoma

R. Scolyer, R. Murali, M. Quinn, 2008, Cancer.

UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.

Gisela Mir Arnau, R. Tothill, S. Fox, 2015, Cancer research.

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma

David L. Marron, D. Hayes, K. Hoadley, 2019, Front. Oncol..

Reduced p16 and Increased Cyclin D1 and pRb Expression Are Correlated With Progression in Cutaneous Melanocytic Tumors

Y. H. Yang, R. Scolyer, Wei Li, 2009, International journal of surgical pathology.

Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients

J. Wilmott, R. Scolyer, John F. Thompson, 2009, Annals of Surgical Oncology.

Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study

J. Braithwaite, G. Mann, R. Scolyer, 2020, BMJ Open.

Absence of distinguishing senescence traits in human melanocytic nevi.

S. Haferkamp, R. Scolyer, R. Kefford, 2012, The Journal of investigative dermatology.

Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi

J. Wilmott, R. Scolyer, G. Long, 2022, The American journal of surgical pathology.

Malignant melanoma in childhood: A clinicopathologic study of 13 cases and comparison with spitz nevi

S. McCarthy, K. Crotty, H. Shaw, 1992, World Journal of Surgery.

Radionuclide Therapy in Melanoma

John F. Thompson, R. Uren, R. Howman-Giles, 2013 .

Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma

J. Wilmott, R. Scolyer, L. Haydu, 2011, Clinical Cancer Research.

Treatment of primary Merkel cell carcinoma: Radiotherapy can be an effective, less morbid alternative to surgery.

J. Stretch, A. Hong, J. Thompson, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

J. Kirkwood, J. McQuade, R. Scolyer, 2020, Cancer medicine.

Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.

Neal P. Kawas, J. Wilmott, R. Scolyer, 2014, Human molecular genetics.

Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma

Yuting Zhang, Richard A Scolyer, R. Scolyer, 2003, Cancer.

The role of cell cycle regulatory proteins in the pathogenesis of melanoma

Wei Li, Richard A Scolyer, R. Scolyer, 2006, Pathology.

Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy

J. Wilmott, R. Scolyer, S. McCarthy, 2019, The American journal of surgical pathology.

Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma

R. Scolyer, Wei Li, A. Sanki, 2007, Pathology.

Pigmented epithelioid melanocytoma.

R. Scolyer, S. McCarthy, J. Thompson, 2004, The American journal of surgical pathology.

Recent advances and important issues in melanoma pathology: an update for oncologists

M. Mihm, R. Scolyer, S. O'toole, 2012 .

Pathology of melanocytic lesions: New, controversial, and clinically important issues

Richard A Scolyer, R. Scolyer, S. McCarthy, 2004, Journal of surgical oncology.

Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.

M. Mihm, R. Scolyer, T. Schatton, 2014, Methods in molecular biology.

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

V. Sondak, M. Mihm, M. Ross, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up

R. Scolyer, S. Soong, A. Francken, 2004, Annals of Surgical Oncology.

23. Primary Melanoma of the Lung

R. Scolyer, J. Bishop, J. Thompson, 2012 .

A 14‐Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic Melanoma

G. Mann, R. Christopherson, R. Scolyer, 2018, Proteomics. Clinical applications.

Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma

R. Saw, D. Damian, J. Thompson, 2014, Journal of surgical oncology.

Evaluation of Sex-Specific Incidence of Melanoma.

D. Whiteman, N. Pandeya, C. Olsen, 2020, JAMA dermatology.

Primary Melanoma of the Lung

R. Scolyer, J. Thompson, 2007, The American surgeon.

Primary pulmonary melanoma

J. Wilt, J. Thompson, 2003 .

Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus.

R. Scolyer, S. McCarthy, R. Murali, 2007, Journal of the American Academy of Dermatology.

Peritoneal melanosis associated with metastatic melanoma involving the omentum.

R. Scolyer, S. McCarthy, P. McKenzie, 2012, Pathology.

Fine-needle biopsy of metastatic melanoma: clinical use and new applications.

R. Scolyer, R. Murali, R. Uren, 2010, The Lancet. Oncology.

Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases.

R. Scolyer, R. Saw, J. Stretch, 2007, American journal of clinical pathology.

Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management

R. Scolyer, R. Saw, J. Stretch, 2007, Annals of Surgical Oncology.

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.

C. Berking, D. Schadendorf, J. Becker, 2015, European journal of cancer.

Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas.

Rory Wolfe, G. McArthur, R. Wolfe, 2006, Archives of dermatology.

Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial.

R. Simes, P. Hersey, A. Coates, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant I mmunotherapy o f P atients W ith H igh-Risk Melanoma U sing V accinia V iral L ysates o f M elanoma: Results o f a R andomized T rial

R. Simes, P. Hersey, A. Coates, 2002 .

Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy

R. Reddel, A. Coates, D. Raghavan, 1983, Journal of surgical oncology.

Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities.

P. Kam, A. Sanki, H. Kroon, 2011, Current problems in surgery.

BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

G. Pupo, R. Scolyer, L. Haydu, 2014, Clinical Cancer Research.

A Novel Immunogen to Modulate Cytokine Production and Promote Immune System Reconstitution in HIV–AIDS

R. Charter, J. Segal, J. Thompson, 2012, American journal of therapeutics.

BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

R. Tothill, G. Mann, R. Scolyer, 2013, Clinical Cancer Research.

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma

N. Hayward, G. Pupo, P. Johansson, 2014, Nature Communications.

Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway

Nam Huh, Iwei Yeh, Eric Talevich, 2015, Nature Genetics.

BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

Sarah-Jane Schramm, G. Mann, Y. H. Yang, 2013, The Journal of investigative dermatology.

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets

J. Pearson, K. Shannon, G. Mann, 2019, Nature Communications.

Histological regression in melanoma: impact on sentinel lymph node status and survival

K. Shannon, R. Scolyer, M. El Sharouni, 2021, Modern Pathology.

Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study

Bruce K Armstrong, Chris Goumas, Scott W Menzies, 2017, JAMA dermatology.

LNK suppresses interferon signaling in melanoma

J. Wilmott, R. Scolyer, Henry Yang, 2019, Nature Communications.

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

J. Pearson, K. Shannon, G. Mann, 2021, Cancer cell.

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

J. Wilmott, R. Scolyer, R. Kefford, 2020, Nature Communications.

Lymphoma occurring in patients with cutaneous melanoma

R. Scolyer, W. Cooper, J. Stretch, 2010, Journal of Clinical Pathology.

Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination

Nam Huh, Lauren E Haydu, Elizabeth Purdom, 2015, Proceedings of the National Academy of Sciences.

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.

J. Madore, J. Wilmott, R. Scolyer, 2019, Cancer cell.

Genetic alterations and personalized medicine in melanoma: progress and future prospects.

D. Schadendorf, K. Flaherty, R. Scolyer, 2014, Journal of the National Cancer Institute.

CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

J. Madore, J. Wilmott, R. Scolyer, 2018, Clinical Cancer Research.

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.

G. Mann, R. Kefford, L. Scurr, 2008, Neoplasia.

The molecular profile of metastatic melanoma in Australia.

G. Mann, R. Scolyer, S. O'toole, 2016, Pathology.

Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma

Lauren E Haydu, Richard A Scolyer, R. Scolyer, 2012, Clinical Cancer Research.

Multi-trait genetic analysis identifies auto-immune loci associated with cutaneous melanoma.

Jianxin Shi, D. Bishop, M. Iles, 2021, The Journal of investigative dermatology.

TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells

G. Mann, J. Wilmott, R. Scolyer, 2014, Oncotarget.

Human Cancer Biology BRAF / NRAS Wild-Type Melanomas Have a High Mutation LoadCorrelatingwith Histologic andMolecular Signatures of UV Damage

R. Tothill, G. Mann, R. Scolyer, 2013 .

wild-type melanomas have a high mutation load correlating with histological and molecular signatures of UV damage

R. Tothill, G. Mann, R. Scolyer, 2013 .

A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma

R. Scolyer, R. Saw, J. Stretch, 2005, Annals of Surgical Oncology.

Surgical treatment of splenic metastases in patients with melanoma.

J. D. de Wilt, W. McCarthy, J. Thompson, 2003, Journal of the American College of Surgeons.

Imaging in cutaneous melanoma

R. Saw, D. Chung, I. Ho Shon, 2008, Nuclear medicine communications.

Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma

J. Wilmott, R. Scolyer, P. Hersey, 2015, Modern Pathology.

Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence

M. Mihm, R. Clark, J. Wilmott, 2020, Nature Cancer.

Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma

R. Scolyer, R. Kefford, G. Long, 2020, Cancers.

The detection and significance of melanoma micrometastases in sentinel nodes.

R. Scolyer, R. Murali, I. Satzger, 2008, Surgical oncology.

PD‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐PD‐1/PD‐L1 clinical trials

J. Madore, J. Wilmott, R. Scolyer, 2015, Pigment cell & melanoma research.

Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution

K. Shannon, R. Scolyer, L. Haydu, 2014, Annals of surgery.

Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients

R. Scolyer, R. Gutzmer, A. Kapp, 2007, Histopathology.

The Prognostic Significance of Isolated HMB-45 or MelanA – Positive Cells in Melanoma Sentinel Lymph Node In Response :

R. Scolyer, R. Murali, H. Shaw, 2008 .

Radioguided Sentinel Lymph Node Mapping and Biopsy in Cutaneous Melanoma

John F. Thompson, O. Nieweg, R. Uren, 2016 .

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

K. Shannon, R. Scolyer, L. Haydu, 2015, Annals of Surgical Oncology.

Sentinel-node biopsy in melanoma.

A. Cochran, B. Cady, John F. Thompson, 2014 .

Melanoma - a management guide for GPs.

R. Scolyer, R. Kefford, J. Thompson, 2012, Australian family physician.

Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma

R. Scolyer, John F. Thompson, S. McCarthy, 2008, The American journal of surgical pathology.

Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination.

R. Scolyer, John F. Thompson, R. Uren, 2006, Surgical oncology clinics of North America.

Surgical management of melanoma: have we made any progress in 100 years?

H. Shaw, J. Thompson, W. S. Handley, 2006 .

The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.

T. Pawlik, M. Ross, A. Eggermont, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated Limb Perfusion in the Management of Patients With Recurrent Limb Melanoma: An Important but Limited Role

J. Wilt, J. Thompson, 2001, Annals of Surgical Oncology.

Melanoma Metastases in Triangular Intermuscular Space Lymph Nodes

R. Uren, H. Shaw, R. Howman-Giles, 1999, Annals of Surgical Oncology.

Variability of cutaneous lymphatic flow rates in melanoma patients

R. Uren, R. Howman-Giles, E. Bernard, 1998, Melanoma research.

Molecular Genomic Profiling of Melanocytic Nevi.

J. Pearson, G. Mann, N. Hayward, 2019, The Journal of investigative dermatology.

Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity

J. Pearson, G. Mann, N. Hayward, 2020, Nature Communications.

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Jeffrey E Gershenwald, Lauren E Haydu, Merrick I Ross, 2017, CA: a cancer journal for clinicians.

Epigenetic pro fi ling for the molecular classi fi cation of metastatic brain tumors

I. Shmulevich, T. Knijnenburg, C. Cobbs, 2019 .

Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma

R. Scolyer, P. Hersey, Xu Dong Zhang, 2007, Modern Pathology.

Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens

R. Scolyer, S. Lo, R. Saw, 2018, Annals of Surgical Oncology.

Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations

R. Scolyer, E. Friedman, J. Thompson, 2021, Advances in Therapy.

Clinical outcomes following surgical treatment of lentigo maligna of the head and neck.

K. Shannon, R. Scolyer, P. Guitera, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatment of Primary Melanomas

M. Ross, M. Henderson, J. Thompson, 2020, Cutaneous Melanoma.

Appropriate excision margins for cutaneous melanomas

E. Friedman, J. Thompson, 2019, The Lancet.

The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas

K. Shannon, R. Scolyer, L. Haydu, 2013, Annals of surgery.

Histopathologic Excision Margin Affects Local Recurrence Rate: Analysis of 2681 Patients With Melanomas ≤2 mm Thick

R. Scolyer, W. McCarthy, E. Starritt, 2005, Annals of surgery.

Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node Biopsy

C. O'brien, K. Shannon, R. Scolyer, 2004, Annals of Surgical Oncology.

Surgical excision margins for primary cutaneous melanoma.

M. Lens, C. Balch, D. Berg, 2009, The Cochrane database of systematic reviews.

Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center

K. Shannon, G. Mann, R. Scolyer, 2017, Modern Pathology.

Data Set for Pathology Reporting of Cutaneous Invasive Melanoma

R. Scolyer, M. Trotter, V. Prieto, 2013, The American journal of surgical pathology.

Patterns of Recurrence and Survival After Lymphadenectomy in Melanoma Patients: Clarifying the Effects of Timing of Surgery and Lymph Node Tumor Burden

L. Haydu, John F. Thompson, A. Spillane, 2013, Annals of Surgical Oncology.

The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center

R. Scolyer, M. Colman, H. Shaw, 2008, Annals of Surgical Oncology.

Interobserver Reproducibility of Histopathologic Prognostic Variables in Primary Cutaneous Melanomas

Sing Kai Lo, Richard A Scolyer, R. Scolyer, 2003, The American journal of surgical pathology.

Optimum excision margins for melanoma

D. Ollila, J. Thompson, 2011, The Lancet.

History of Melanoma

R. Scolyer, R. Kefford, G. Stevens, 2018 .

A History of Melanoma: From Hunter to Morton

J. Kirkwood, C. Balch, A. Sober, 2020, Cutaneous Melanoma.

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

J. Madore, J. Wilmott, R. Scolyer, 2017, Clinical Cancer Research.

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients

G. Mann, R. Christopherson, G. Pupo, 2014, Pigment cell & melanoma research.

Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis

O. Nieweg, R. Uren, J. Thompson, 2019, Annals of Surgical Oncology.

Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma

K. Shannon, R. Scolyer, G. Long, 2021, Annals of Surgical Oncology.

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

A. Cochran, K. Delman, K. Bilimoria, 2022, Annals of Surgical Oncology.

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

V. Sondak, M. Ross, K. Shannon, 2022, Annals of Surgical Oncology.

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.

K. Shannon, J. Wilmott, R. Scolyer, 2019, The Lancet. Oncology.

Cutaneous melanoma

Richard A Scolyer, R. Scolyer, R. Kefford, 2005, The Lancet.

Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma

S. Soong, A. Francken, H. Hoekstra, 2008, Annals of Surgical Oncology.

Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.

T. Pawlik, M. Ross, J. Gershenwald, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Melanoma Prognosis and Staging

V. Sondak, J. Kirkwood, R. Scolyer, 2019, Cutaneous Melanoma.

Desmoplastic Melanoma

R. Scolyer, John F. Thompson, Teresa A. Bailey, 2019, Melanoma.

Response to Comment on "Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does Not Provide Reliable Staging: Results From a Large Multicenter Trial" by Stahlie et al.

O. Nieweg, M. Faries, R. Uren, 2019, Annals of surgery.

More on Adjuvant Therapy in Resected Melanoma.

M. Faries, S. Stern, J. Thompson, 2018, The New England journal of medicine.

The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)

R. Elashoff, A. Cochran, D. Morton, 2010, Annals of Surgical Oncology.

Methods of melanoma detection and of skin monitoring for individuals at high risk of melanoma: new Australian clinical practice

S. Menzies, P. Guitera, J. Kelly, 2018, The Medical journal of Australia.

Evaluation of Incomplete Sentinel Node Biopsy Procedures and Sentinel Node Positivity Rates as Surgical Quality-Assurance Parameters in Melanoma Patients

K. Shannon, L. Haydu, John F. Thompson, 2012, Annals of Surgical Oncology.

Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients

B. Vrouenraets, R. Uren, P. Niewind, 1997, Melanoma research.

Current management of patients with melanoma who are found to be sentinel node‐positive

R. Saw, A. Spillane, J. Stretch, 2019, ANZ journal of surgery.

Surgeons’ Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey

K. Shannon, John F. Thompson, R. Saw, 2012, Annals of Surgical Oncology.

Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas.

R. Scolyer, John F. Thompson, S. Lo, 2021, Pathology.

Reconstruction after wide excision of primary cutaneous melanomas: part II--the extremities.

John F. Thompson, J. Stretch, M. Quinn, 2009, The Lancet. Oncology.

Correlation Between Preoperative Lymphoscintigraphy and Metastatic Nodal Disease Sites in 362 Patients With Cutaneous Melanomas of the Head and Neck

C. O'brien, K. Shannon, R. Scolyer, 2004, Annals of surgery.

Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients.

M. Ross, R. Scolyer, A. Cochran, 2005, Journal of the American College of Surgeons.

International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin

L. Haydu, D. Coit, M. Sabel, 2014, Annals of Surgical Oncology.

A novel hypoxia-associated subset of FN1highMITFlow melanoma cells: identification, characterization, and prognostic value

R. Scolyer, L. Haydu, J. J. van den Oord, 2014, Modern Pathology.

Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors

M. Mihm, S. Ogino, R. Scolyer, 2013, Modern Pathology.

Recurrent heteroplasmy for the MT-ATP6 p.Ser148Asn (m.8969G>A) mutation in patients with syndromic congenital sideroblastic anemia of variable clinical severity

M. Fleming, V. Rodriguez, M. Heeney, 2018, Haematologica.

Reflection and Reaction

John F. Thompson, R. Uren, H. Shaw, 2005 .

Axillary and Epitrochlear Lymph Node Dissection for Melanoma

C. Balch, K. McMasters, D. Tyler, 2020, Cutaneous Melanoma.

Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma

J. Wilmott, R. Scolyer, L. Haydu, 2012, Histopathology.

Intestinal and Multivisceral Transplantation in Children

J. Moon, John F. Thompson, T. Ueno, 2006, Annals of surgery.

100 Multivisceral Transplants at a Single Center

E. Pretto, J. Moon, J. Augenstein, 2005, Annals of surgery.

Intestinal transplantation in children: A summary of clinical outcomes and prognostic factors in 108 patients from a single center

J. Moon, J. Gaynor, S. Nishida, 2007, Journal of Gastrointestinal Surgery.

Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases

J. Wilmott, R. Scolyer, P. Hersey, 2015, Modern Pathology.

Incidence of new primary melanomas after diagnosis of stage III and IV melanoma.

D. Schadendorf, R. Scolyer, L. Haydu, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dynamics of Chemokine, Cytokine, and Growth Factor Serum Levels in BRAF-Mutant Melanoma Patients during BRAF Inhibitor Treatment

J. Wilmott, R. Scolyer, L. Haydu, 2014, The Journal of Immunology.

Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I)

R. Elashoff, V. Sondak, A. Cochran, 2012, Annals of Surgical Oncology.

Human Cancer Biology Distinguishing Clinicopathologic Features of Patients with V 600 E and V 600 K BRAF-Mutant Metastatic Melanoma

R. Scolyer, L. Haydu, R. Kefford, 2012 .

Intestinal and multivisceral transplantation.

A. Tzakis, A. Pinna, P. Ruiz, 2004, World journal of surgery.

The role of intestinal transplantation in the management of babies with extensive gut resections.

S. Nishida, D. Levi, J. Madariaga, 2003, Journal of pediatric surgery.

Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets

J. Wilmott, R. Scolyer, G. Long, 2021, Cancers.

Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia

James X. Sun, K. Delman, D. Tyler, 2020, Annals of Surgical Oncology.

Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.

James X. Sun, K. Delman, D. Tyler, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients

James X. Sun, K. Delman, D. Tyler, 2020, Annals of Surgical Oncology.

Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients

J. Wilmott, R. Scolyer, G. Long, 2019, Oncoimmunology.

First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era?

Marina Teras, P. Pata, H. Kroon, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.

V. Sondak, J. Taube, M. Ross, 2019, The Lancet. Oncology.

Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis

James X. Sun, K. Delman, D. Tyler, 2019, Annals of Surgical Oncology.

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients

J. Madore, J. Wilmott, R. Scolyer, 2018, Oncoimmunology.

Mucosal Hyperplasia in Infant With Jejunal Web

T. Levin, Bryan Rudolph, S. Borenstein, 2013, Journal of pediatric gastroenterology and nutrition.

Current status of small bowel transplantation in children: update 2003.

John F. Thompson, A. Tzakis, Tomoaki Kato, 2003, Pediatric clinics of North America.

Rapid Communication: Increased Frequency of TCRγδ+ T Cells in Disease-Free Survivors Following T Cell-Depleted, Partially Mismatched, Related Donor Bone Marrow Transplantation for Leukemia

A. Gee, P. Henslee-Downey, R. Parrish, 1996 .

Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines

S. Soong, A. Francken, H. Hoekstra, 2007, Annals of Surgical Oncology.

Treatment of in-transit Merkel cell carcinoma by isolated limb infusion with cytotoxic drugs

P. Kam, R. Saw, Jake Hindmarch, 2022, Journal of surgical case reports.

Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.

Samuel Mueller, Sarah-Jane Schramm, Varsha Tembe, 2016, The Journal of investigative dermatology.

Management of Regional Lymph Nodes in Patients with Merkel Cell Carcinoma Following a Positive Sentinel Node Biopsy: Less May be More, But is Either Enough?

A. Guminski, G. Hruby, J. Thompson, 2018, Annals of Surgical Oncology.

Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas

J. Pearson, G. Mann, N. Hayward, 2017, Laboratory Investigation.

The value of sentinel node biopsy in patients with primary cutaneous melanoma.

J. Thompson, 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Sentinel node mapping for melanoma: results of trials and current applications.

H. Shaw, J. Thompson, 2007, Surgical oncology clinics of North America.

Safety and Efficacy of Isolated Limb Infusion With Cytotoxic Drugs in Elderly Patients With Advanced Locoregional Melanoma

P. Kam, H. Kroon, J. Thompson, 2009, Annals of surgery.

Redefining Disease and Pharmaceutical Targets Through Molecular Definitions and Personalized Medicine

C. Webb, B. Littman, J. Thompson, 2010 .

Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis.

R. Scolyer, J. Stretch, R. Murali, 2010, Pathology.

Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility

J. Pearson, K. Shannon, G. Mann, 2018, International journal of cancer.

CYCLOSPORIN A IN OLIGURIC RENAL TRANSPLANT RECIPIENTS

A. Sheil, G. Duggin, B. Hall, 1981, The Lancet.

Cross-Platform Omics Prediction procedure: a game changer for implementing precision medicine in patients with stage-III melanoma

Dario Strbenac, Ellis Patrick, Samuel Mueller, 2020, bioRxiv.

Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma

A. von Deimling, J. Wilmott, R. Scolyer, 2013, The American journal of surgical pathology.

Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes

R. Scolyer, S. Mocellin, John F. Thompson, 2013, Pigment cell & melanoma research.

Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.

Maria L. Wei, Eric A. Smith, J. Stein, 2020, JAMA dermatology.

Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers.

I. Zalaudek, A. Hauschild, F. Egberts, 2019, Journal of the National Cancer Institute.

The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma

R. Scolyer, S. McCarthy, H. Shaw, 2006, Journal of cutaneous pathology.

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients

G. Mann, R. Christopherson, R. Scolyer, 2014, Clinical & Experimental Metastasis.

Surgical Management of Distant Melanoma Metastases

Jeffrey E. Lee, C. Balch, M. Faries, 2019, Cutaneous Melanoma.

An international, randomized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites

R. Elashoff, D. Morton, John F. Thompson, 2007 .

Lymphedema After Complete Axillary Node Dissection for Melanoma: Assessment Using a New, Objective Definition

S. Lo, J. D. de Wilt, E. Starritt, 2004, Annals of surgery.

Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.

P. V. van Diest, R. Scolyer, A. Witkamp, 2020, JAMA dermatology.

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

Jeffrey E Gershenwald, Merrick I Ross, Natale Cascinelli, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicopathologic features associated with efficacy and long‐term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors

J. Wilmott, R. Scolyer, R. Kefford, 2015, Cancer.

Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma

R. Scolyer, A. Eggermont, A. Testori, 2007, Clinical Cancer Research.

Variation in cutaneous lymphatic flow rates

R. Uren, R. Howman-Giles, J. Thompson, 1997, Annals of Surgical Oncology.

Role of lymphoscintigraphy for selective sentinel lymphadenectomy.

John F. Thompson, R. Uren, D. Chung, 2005, Cancer treatment and research.

GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study

John F. Thompson, F. Rapport, A. Cust, 2020, BJGP open.

False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma

R. Turner, R. Saw, A. Menzies, 2019, Annals of Surgical Oncology.

The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.

R. Scolyer, A. Eggermont, L. Haydu, 2014, European journal of cancer.

Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.

Andrew Hayen, Les Irwig, Katy J L Bell, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients

R. Scolyer, R. Murali, J. Thompson, 2011, Annals of surgery.

Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system.

R. Scolyer, J. Gershenwald, L. Haydu, 2019, European journal of cancer.

The Challenge of Defining Guidelines for Sentinel Lymph Node Biopsy in Patients with Thin Primary Cutaneous Melanomas

V. Sondak, J. Gershenwald, D. Coit, 2012, Annals of Surgical Oncology.

The Role of Sentinel Lymph Node Biopsy in Patients with Merkel Cell Carcinoma: Uncertainty Prevails

G. Hruby, J. Thompson, 2014, Annals of Surgical Oncology.

Ultrasound assessment of lymph nodes in the management of early‐stage melanoma

L. Haydu, A. Sanki, R. Uren, 2011, Journal of surgical oncology.

Topical diphencyprone immunotherapy for cutaneous metastatic melanoma

K. Shannon, R. Saw, D. Damian, 2009, The Australasian journal of dermatology.

The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients

J. Craig, R. Morton, J. Thompson, 2009, Annals of Surgical Oncology.

Follow‐up schedules after treatment for malignant melanoma

S. Soong, A. Francken, H. Hoekstra, 2008, The British journal of surgery.

Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy)

P. Hersey, M. Quinn, W. McCarthy, 2005, Melanoma research.

Sentinel lymph nodes in malignant melanoma: Extended histopathologic evaluation improves diagnostic precision

R. Scolyer, S. McCarthy, J. Thompson, 2004, Cancer.

Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma.

R. Scolyer, John F. Thompson, S. McCarthy, 2004, American journal of clinical pathology.

Ultrasound Examination of Sentinel Nodes in the Initial Assessment of Patients With Primary Cutaneous Melanoma

R. Scolyer, M. Quinn, R. Uren, 2004, Annals of Surgical Oncology.

Elemental bio-imaging of melanoma in lymph node biopsies.

R. Scolyer, D. Hare, R. Grimm, 2009, The Analyst.

Cost-effectiveness of Adding FDG-PET or CT to the Diagnostic Work-up of Patients With Stage III Melanoma

W. Oyen, O. Hoekstra, E. J. van der Jagt, 2012, Annals of surgery.

The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma

John F. Thompson, R. Morton, R. Uren, 2007, Annals of Surgical Oncology.

Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes.

R. Scolyer, R. Murali, J. Thompson, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sentinel Node Status Prediction by Four Statistical Models: Results From a Large Bi-Institutional Series (n = 1132)

Simone Mocellin, Richard A Scolyer, R. Scolyer, 2009, Annals of surgery.

PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients

J. Wilmott, R. Scolyer, L. Haydu, 2015, Clinical Cancer Research.

Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas

J. Wilmott, R. Scolyer, S. O'toole, 2014, Pathology.

BRAF Inhibitor Treatment BRAF-Mutant Melanoma Patients during Growth Factor Serum Levels in Dynamics of Chemokine , Cytokine , and

J. Wilmott, R. Scolyer, L. Haydu, 2014 .

Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries

R. Scolyer, R. Saw, C. Sandroussi, 2013, Journal of surgical oncology.

Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy

John F. Thompson, R. Saw, A. Haydon, 2021, ANZ journal of surgery.

The role of regional chemotherapy for advanced limb melanoma in the era of potentially effective systemic therapies

John F. Thompson, R. Read, J. Thompson, 2021, Melanoma research.

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)

James X. Sun, Lesly A. Dossett, V. Sondak, 2021, Cancer.

Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.

Jeffrey E. Lee, M. Ross, K. Shannon, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymph Node Ratio Provides Prognostic Information in Addition to American Joint Committee on Cancer N Stage in Patients With Melanoma, Even If Quality of Surgery Is Standardized

A. Spillane, J. Winstanley, J. Thompson, 2011, Annals of surgery.

Defining Lower Limb Lymphedema After Inguinal or Ilio-Inguinal Dissection in Patients With Melanoma Using Classification and Regression Tree Analysis

K. Byth, John F. Thompson, R. Saw, 2008, Annals of surgery.

Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications

K. Shannon, R. Saw, A. Spillane, 2017, Annals of Surgical Oncology.

Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy?

H. Shaw, J. Thompson, 2004, Annals of Surgical Oncology.

Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma.

P Rod Dunbar, P. Dunbar, H. Reynolds, 2007, The Lancet. Oncology.

Plasma cells in primary melanoma. Prognostic significance and possible role of IgA

J. Wilmott, R. Scolyer, D. Massi, 2016, Modern Pathology.

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

Jeffrey E. Lee, R. Elashoff, D. Morton, 2017, Annals of Surgical Oncology.

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

G. Pupo, J. Wilmott, R. Scolyer, 2017, Clinical Cancer Research.

Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.

D. Damian, J. Thompson, 2007, Journal of the American Academy of Dermatology.

Reply to M. Perier-Muzet et al.

Lauren E Haydu, Dirk Schadendorf, Richard A Scolyer, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sex Differences in Melanoma Survival are Not Related to Mitotic Rate of the Primary Tumor

J. Coebergh, R. Scolyer, A. Eggermont, 2015, Annals of Surgical Oncology.

Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastases

Jeffrey E. Lee, R. Elashoff, A. Testori, 2012 .

Specialized Cancer Procedures and Surgery

D. Tyler, B. Coventry, H. Kroon, 2014 .

Factors Predictive of Acute Regional Toxicity After Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma Patients

P. Kam, M. Moncrieff, H. Kroon, 2009, Annals of Surgical Oncology.

The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: a retrospective cohort study.

J. Wilmott, R. Scolyer, S. Lo, 2020, Journal of the American Academy of Dermatology.

Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients

O. Nieweg, R. Uren, D. Chung, 2019, Annals of Surgical Oncology.

Chemoablation of metastatic melanoma with rose bengal (PV-10).

M. Ross, B. Coventry, C. Scoggins, 2010 .

Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma

P. Kam, A. Doubrovsky, P. Lindnér, 2002, Annals of Surgical Oncology.

Isolated Limb Infusion for Recurrent and Locally Metastatic Limb Melanoma

B. Coventry, H. Kroon, J. Thompson, 2018 .

Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience

P. Kam, M. Moncrieff, H. Kroon, 2008, Annals of Surgical Oncology.

Isolated limb infusion with melphalan for recurrent limb melanoma : a simple alternative to isolated limb perfusion

P. Kam, R. Saw, R. Waugh, 1994 .

Australian Multicenter Study of Isolated Limb Infusion for Melanoma

B. Coventry, A. Barbour, B. Smithers, 2016, Annals of surgical oncology.

Does Increased Experience with Isolated Limb Infusion for Advanced Limb Melanoma Influence Outcome? A Comparison of Two Treatment Periods at a Single Institution

P. Kam, H. Kroon, J. Thompson, 2011, Annals of Surgical Oncology.

Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma

P. Kam, H. Kroon, J. Thompson, 2009, Cancer.

Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity

P. Kam, R. Scolyer, M. Moncrieff, 2008, Annals of Surgical Oncology.

Long-term Results of Hyperthermic, Isolated Limb Perfusion for Melanoma: A Reflection of Tumor Biology

P. Kam, A. Sanki, J. Thompson, 2007, Annals of surgery.

Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma

P. Kam, P. Lindnér, M. Colman, 2001 .

Pharmacokinetics of melphalan during isolated limb infusion for melanoma

P. Kam, I. Ramzan, J. Thompson, 1996 .

Is Melphalan Dose Adjustment According to Ideal Body Weight Useful in Isolated Limb Infusion for Melanoma?

P. Kam, L. Haydu, H. Kroon, 2012, Annals of Surgical Oncology.

Isolated limb perfusion for melanoma: results and complications

B. Vrouenraets, O. Nieweg, B. Kroon, 2003 .

Determinants of acute regional toxicity following isolated limb perfusion for melanoma

C. Ingvar, S. Eksborg, I. Ramzan, 1996, Melanoma research.

Isolated Limb Infusion of the Extremity

P. Kam, H. Kroon, J. Thompson, 2015 .

Chapter 5 Isolated Limb Infusion of the Extremity

P. Kam, H. Kroon, J. Thompson, 2015 .

Isolated Limb Infusion as Palliative Treatment for Advanced Limb Disease in Patients with AJCC Stage IV Melanoma

P. Kam, H. Kroon, J. Thompson, 2009, Annals of Surgical Oncology.

Pathologic examination of sentinel lymph nodes from melanoma patients.

R. Scolyer, S. McCarthy, R. Murali, 2008, Seminars in diagnostic pathology.

Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma–Mass Spectrometry

R. Scolyer, R. Bourne, J. Stretch, 2008, Annals of Surgical Oncology.

The rationale for sentinel-node biopsy in primary melanoma

A. Cochran, D. Morton, John F. Thompson, 2008, Nature Clinical Practice Oncology.

The utility of ultrasound in patients with melanoma

A. Sanki, John F. Thompson, R. Uren, 2007, Expert review of anticancer therapy.

Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients.

Robert Howman-Giles, John F. Thompson, B. Vrouenraets, 1997 .

Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.

B. Coventry, A. Barbour, B. Smithers, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma

M. Ross, B. Coventry, C. Scoggins, 2014, Annals of Surgical Oncology.

Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors

J. Thompson, C. M. Byrne, 2006, Expert review of anticancer therapy.

Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma

R. Elashoff, A. Cochran, D. Morton, 2005 .

Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).

Martin F. Mihm, M. Kutner, G. Botti, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Lymphatic mapping and sentinel node biopsy: the data unclouded by speculation.

A. Cochran, J. Thompson, 2008, Archives of dermatology.

Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases

J. Madore, J. Wilmott, R. Scolyer, 2015, Annals of Surgical Oncology.

Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes.

R. Scolyer, R. Murali, J. Thompson, 2013, European Journal of Surgical Oncology.

Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model

Dung-Tsa Chen, Hui-Yi Lin, Richard A. Scolyer, 2010, Annals of Surgical Oncology.

Is there a Role for Isolated Limb Perfusion With Tumor Necrosis Factor in Patients With Melanoma?

J. Wilt, J. Thompson, 2004, Annals of Surgical Oncology.

Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma.

R. Scolyer, Hui-Yi Lin, A. Sanki, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma.

P. Kam, J. Thompson, 2008, Surgical oncology clinics of North America.

[Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion].

H. Kroon, J. Thompson, H. Hoekstra, 2009, Nederlands tijdschrift voor geneeskunde.

Value of prophylactic isolated limb perfusion (ILP) for stage I high risk malignant melanoma: a randomised phase III trial

A. Eggermont, B. Kroon, F. Lejeune, 1997 .

Major Amputation for Irresectable Extremity Melanoma After Failure of Isolated Limb Infusion

P. Kam, H. Kroon, J. Thompson, 2009, Annals of Surgical Oncology.

The Sydney Melanoma Unit--a multidisciplinary melanoma treatment center.

J. Stretch, W. McCarthy, H. Shaw, 2003, The Surgical clinics of North America.

Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities

A. Hong, K. Tonks, G. Hruby, 2018, Annals of Surgical Oncology.

Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity

P. Kam, J. Thompson, 2010, Expert opinion on drug metabolism & toxicology.

Current status of isolated limb infusion with mild hyperthermia for melanoma

P. Kam, J. Thompson, 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Melanoma management in 2007.

R. Scolyer, R. Kefford, J. Thompson, 2007, Australian family physician.

Isolated limb infusion for melanoma: Results of an elective double infusion protocol

P. Kam, K. Shannon, R. Saw, 1995 .

Cutaneous melanoma in the era of molecular profiling

R. Scolyer, R. Kefford, J. Thompson, 2009, The Lancet.

Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma

R. Scolyer, R. Uren, J. Wilt, 2011, Annals of Surgical Oncology.

Selective sentinel lymphadenectomy: progress to date and prospects for the future.

R. Scolyer, J. Stretch, R. Uren, 2005, Cancer treatment and research.

Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour?

R. Scolyer, J. D. de Wilt, B. McCaughan, 2005, Melanoma research.

Hepatic surgery for metastatic melanoma

R. Essner, A. Bilchik, J. Thompson, 2003 .

Surgical resection of pulmonary metastatic melanoma: A review of 83 thoracotomies

A. Coates, B. McCaughan, J. Thompson, 1996 .

Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma

Jeffrey E. Lee, R. Elashoff, D. Morton, 2012, Annals of surgery.

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.

K. Shannon, G. Mann, R. Scolyer, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Melanoma of the Vulva and Vagina: Principles of Staging and Their Relevance to Management Based on a Clinicopathologic Analysis of 85 Cases

R. Scolyer, L. Haydu, J. Stretch, 2015, Annals of surgical oncology.

Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease

K. Shannon, R. Scolyer, L. Haydu, 2014, Annals of Surgical Oncology.

Evaluating and Embracing Modern Imaging Technology to Guide Sentinel Node Biopsy for Melanoma

M. Moncrieff, J. Thompson, 2022, Annals of Surgical Oncology.

The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients

B. Hesse, R. Scolyer, M. Nielsen, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

False Negative Sentinel Lymph Node Biopsies in Melanoma May Result From Deficiencies in Nuclear Medicine, Surgery, or Pathology

R. Scolyer, D. Hoon, Wei Li, 2008, Annals of surgery.

Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma.

R. Elashoff, A. Cochran, H. Hoekstra, 2017, Journal of the American College of Surgeons.

EDITORIAL — What is a «sentinel» lymph node?

John F. Thompson, R. Uren, J. Thompson, 2000 .

Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens

R. Scolyer, S. McCarthy, J. Stretch, 2004, Melanoma research.

Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion From MLST-II: Multi-Institutional Propensity Score Matched Analysis.

James X. Sun, Lesly A. Dossett, T. Hughes, 2020, Journal of the American College of Surgeons.

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial

H. Dhillon, A. Hong, G. Fogarty, 2011, BMC Cancer.

Surgical Technique for Open Inguinal Lymphadenectomy

A. Spillane, J. Thompson, 2018 .

Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease

R. Elashoff, V. Sondak, D. Elashoff, 2019, Annals of Surgical Oncology.

Adjuvant nodal irradiation in melanoma – Authors' reply

M. Henderson, B. Burmeister, J. Thompson, 2012 .

Prognostic F actors A nalysis o f 1 7,600 M elanoma P atients: Validation o f t he A merican J oint C ommittee o n C ancer Melanoma S taging S ystem

M. Ross, M. Atkins, J. Kirkwood, 2001 .

Sentinel node biopsy for melanoma: Where have we been and where are we going?

R. Scolyer, J. Stretch, R. Uren, 2004, Annals of Surgical Oncology.

Mitotic rate in melanoma should be recorded as the number of mitoses per mm² (not per high power field): surgeons tell your pathologists!

R. Scolyer, John F. Thompson, J. Thompson, 2013, American journal of surgery.

Lymphatic mapping and sentinel lymph node biopsy: the concept

J. Thompson, 2003 .

The prognosis of patients with thick primary melanomas: Is regional lymph node status relevant, and does removing positive regional nodes influence outcome?

H. Shaw, J. Thompson, 2002, Annals of Surgical Oncology.

Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?

C. O'brien, M. Quinn, W. McCarthy, 2001, Head & neck.

Ultrasound Examination of the Lymphatic Drainage Area and Regional Lymph Nodes in Melanoma Patients with In-Transit Metastases

O. Nieweg, R. Uren, D. Chung, 2020, Annals of Surgical Oncology.

Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging

R. Elashoff, D. Elashoff, A. Cochran, 2019, Annals of surgery.

Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases

J. Madore, J. Wilmott, R. Scolyer, 2017, Annals of Surgical Oncology.

Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases

R. Scolyer, L. Haydu, R. Karim, 2013, Annals of Surgical Oncology.

Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma.

A. Cochran, D. Morton, J. Thompson, 2007, Annals of surgery.

Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal

A. Cooper, O. Nieweg, J. Thompson, 2017, The Australasian journal of dermatology.

Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas

J. Pearson, G. Mann, N. Hayward, 2020, Cancer Immunology Research.

Sentinel Lymph Nodes Containing Very Small (<0.1 mm) Deposits of Metastatic Melanoma Cannot Be Safely Regarded as Tumor-Negative

R. Scolyer, S. McCarthy, R. Murali, 2012, Annals of surgical oncology.

In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma

R. Morton, J. Thompson, 2009, Annals of Surgical Oncology.

Sentinel node biopsy for breast cancer: then and now

John F. Thompson, A. Spillane, J. Thompson, 2012, ANZ journal of surgery.

Primary Melanoma Location on the Scalp is an Important Risk Factor for Brain Metastasis: A Study of 1,687 Patients with Cutaneous Head and Neck Melanomas

K. Shannon, L. Haydu, R. Saw, 2014, Annals of Surgical Oncology.

Lymphatic Drainage From Peri-Umbiiical Skin to Internal Mammary Nodes

W. McCarthy, R. Uren, H. Shaw, 1995, Clinical nuclear medicine.

Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients.

R. Scolyer, John F. Thompson, K. Dabbs, 2010, Journal of the American College of Surgeons.

In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up?

J. Thompson, 2021, Annals of Surgical Oncology.

Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas

R. Scolyer, J. J. van den Oord, P. Rutkowski, 2021, International journal of molecular sciences.

Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases

F. Braet, Ming-Wei Lin, S. Adelstein, 2008 .

Melanoma Metastases in Regional Lymph Nodes Are Accurately Detected by Proton Magnetic Resonance Spectroscopy of Fine-Needle Aspirate Biopsy Samples

R. Somorjai, B. Dolenko, Edward M. Hsiao, 2005, Annals of Surgical Oncology.

Antimony concentrations in nodal tissue can confirm sentinel node identity

R. Scolyer, S. McCarthy, J. Stretch, 2004, Modern Pathology.

Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens

R. Scolyer, R. Bourne, C. Mountford, 2003, Melanoma research.

Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients.

R. Scolyer, A. Beavis, P. Doble, 2003, The Analyst.

Reply to I. Satzger et al

R. Scolyer, R. Murali, J. Thompson, 2011 .

Can histologic parameters of melanoma metastases in sentinel lymph nodes reliably select patients who can be safely spared completion lymph node dissection?

R. Scolyer, R. Murali, J. Thompson, 2010, Annals of surgery.

Location of melanoma metastases in sentinel lymph nodes: what are the implications for histologic processing of sentinel lymph nodes in routine practice?

R. Scolyer, R. Murali, J. Thompson, 2010, The American journal of surgical pathology.

Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients.

O. Nieweg, R. Uren, J. Thompson, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

athologic examination of sentinel lymph nodes from elanoma patients

R. Murali, J. Thompson, ichard A. Scolyer, 2008 .

Sentinel lymph node biopsy: unresolved questions

O. Nieweg, R. Uren, J. Thompson, 2003 .

Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients?

Jonathan R. Clark, C. O'brien, K. Shannon, 2008, Annals of surgical oncology.

Three‐dimensional visualization of skin lymphatic drainage patterns of the head and neck

H. Reynolds, R. Uren, J. Thompson, 2009, Head & neck.

Metastatic occlusion of a lymphatic collecting vessel in a patient with cutaneous melanoma and clinically normal lymph nodes.

R. Uren, D. Chung, R. Howman-Giles, 2007, Clinical nuclear medicine.

Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer.

Richard A Scolyer, R. Scolyer, John F. Thompson, 2004, Pathology.

Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine

R. Scolyer, D. Morton, D. Hoon, 2008, Clinical Cancer Research.

Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02.

M. Ross, B. Coventry, C. Scoggins, 2014 .

Expression of glucose‐regulated stress protein GRP78 is related to progression of melanoma

R. Scolyer, P. Hersey, W. Cooper, 2009, Histopathology.

BAP1-inactivated spitzoid naevi.

R. Scolyer, S. McCarthy, R. Vilain, 2015, The American journal of surgical pathology.

Chapter 5 – Brain Metastases from Melanoma

G. Long, A. Hong, M. Lyle, 2016 .

Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma

R. Scolyer, John F. Thompson, R. Murali, 2009, Annals of surgery.

Time for comprehensive reporting of MSLT-I – Authors' reply

R. Uren, H. Shaw, J. Thompson, 2006 .

Magnetic resonance spectroscopy in the management of melanoma

R. Scolyer, C. Mountford, John F. Thompson, 2005 .

Micrometastatic Melanoma Cell Accumulation in Sentinel Lymph Nodes Containing Dendritic + Long-Term Protective Effect of Mature DC-LAMP

12, R. Scolyer, A. Eggermont, 2007 .

Lymphatic mapping and sentinel node biopsy for melanoma

J. Thompson, R. Uren, J. Thompson, 2001, Expert review of anticancer therapy.

Multiplex melanoma families are enriched for polygenic risk

M. Iles, D. Duffy, N. Martin, 2020, Human molecular genetics.

Digital papillary adenocarcinoma: a tumour that should be considered in the differential diagnosis of neoplasms involving the digits

R. Scolyer, R. Karim, S. McCarthy, 2013, Pathology.

Predicting Survival Outcome of Localized Melanoma: An Electronic Prediction Tool Based on the AJCC Melanoma Database

P. Gimotty, J. Gershenwald, C. Balch, 2010, Annals of Surgical Oncology.

A Selective Approach to Resection of Cystic Lesions of the Pancreas : Results From 539 Consecutive Patients

A. Cochran, D. Morton, J. Thompson, 2007 .

First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality

R. Scolyer, H. Dhillon, A. Hong, 2015, BMC Research Notes.

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

L. Haydu, A. Hong, G. Fogarty, 2014, BMC Research Notes.

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis

G. Mann, N. Hayward, J. Wilmott, 2018, British Journal of Cancer.

Single-Dose Gentamicin Clearance Is a Predictor of Creatinine Clearance in Spinal Man

J. Segal, J. Thompson, T. A. Gilman, 2009, American journal of therapeutics.

Correct identification of a sentinel node postselective lymphadenectomy using antimony levels.

R. Scolyer, John F. Thompson, Jonathan Stretch, 2008, Melanoma research.

Models for Predicting Melanoma Outcome

P. Gimotty, J. Gershenwald, L. Haydu, 2020, Cutaneous Melanoma.

Imaging Sentinel Lymph Nodes

R. Uren, D. Chung, R. Howman-Giles, 2015, Cancer journal.

Lymphatic drainage patterns from primary cutaneous tumours of the forehead: refining the recommendations for selective neck dissection.

R. Uren, J. Thompson, M. Wiener, 2014, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients

John F. Thompson, R. Uren, R. Howman-Giles, 1998, Annals of Surgical Oncology.

Nuclear medicine aspects of melanoma and breast lymphatic mapping.

R. Uren, D. Chung, R. Howman-Giles, 2004, Seminars in oncology.

Teaching points on lymphatic mapping for melanoma from the Sydney Melanoma Unit.

John F. Thompson, R. Uren, J. Thompson, 2004, Seminars in oncology.

Anomalous Lymphatic Drainage Patterns in Patients with Cutaneous Melanoma

R. Uren, J. Thompson, 2001, Tumori.

MammaryLymphoscintigraphyin Breast Cancer

R. Uren, R. Howman-Giles, D. Malouf, 1995 .

The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study.

F. al-Azzawi, M. Whitehead, M. Wahab, 2002, Human reproduction.

Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.

M. Fulham, W. Selby, E. Prakoso, 2011, Gastrointestinal endoscopy.

Can We Better Identify Thin Cutaneous Melanomas That are Likely to Metastasize and Cause Death?

R. Scolyer, R. Murali, J. Thompson, 2012, Annals of Surgical Oncology.

Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma

K. Shannon, R. Scolyer, L. Haydu, 2012, Annals of surgical oncology.

Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system

K. Shannon, R. Scolyer, Kevin B. Kim, 2020, Cancer.

The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients.

R. Scolyer, R. Murali, H. Shaw, 2008, The American journal of surgical pathology.

Quality of life patient-reported outcomes for locally advanced cutaneous melanoma

C. Gwaltney, Mona L. Martin, J. Zager, 2017, Melanoma research.

Sentinel node biopsy

J. Thompson, J. Thompson, 1997, Journal of surgical oncology.

Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage iiib/c BRAF-V600 mutation positive melanoma.

K. Shannon, R. Scolyer, R. Kefford, 2016 .

Management of the Parotid/Neck Following a Positive Sentinel Node Biopsy in Patients with Cutaneous Melanoma of the Head and Neck

S. Ch’ng, J. Thompson, E. Tan-Gore, 2019, Difficult Decisions in Surgery: An Evidence-Based Approach.

Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia

Graham Mann, Chris Goumas, S. Menzies, 2018, Annals of Surgical Oncology.

Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians’ perspectives and models of care

S. Menzies, L. Irwig, L. Rychetnik, 2012, BMC Health Services Research.

Guidelines for imaging in cutaneous melanoma

R. Saw, D. Chung, I. Ho Shon, 2008, Nuclear medicine communications.

Internal mammary node metastasis from primary cutaneous melanoma on the anterior chest

R. Saw, R. Uren, J. Thompson, 2005, ANZ journal of surgery.

Making sense of the melanoma information tsunami.

Kevin B. Kim, J. Thompson, 2014, Melanoma management.

Significant impact of HLA class I allele expression on outcome in melanoma patients treated with an allogeneic melanoma cell lysate vaccine. Final analysis of SWOG-9035

V. Sondak, J. Sosman, J. Unger, 2004 .

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

R. Scolyer, L. Haydu, H. Dhillon, 2019, Trials.

Should patients with melanoma brain metastases receive adjuvant whole-brain radiotherapy?

A. Hong, G. Fogarty, J. Thompson, 2015, The Lancet. Oncology.

Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread

K. Shannon, R. Scolyer, G. Long, 2022, Melanoma research.

Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.

R. Scolyer, I. Davis, R. Murali, 2011, European journal of cancer.

Lone Stent-Graft Treatment of Symptomatic Gluteal Artery Aneurysm.

A. Watkinson, C. E. Western, J. Thompson, 2016, Annals of vascular surgery.

Distinct Immune Cell Popu lations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1 / Anti-CTLA-4 Combined Therapy Graphical

J. Madore, J. Wilmott, R. Scolyer, 2019 .

T10B9 MONOCLONAL ANTIBODY: SHORT ACTING NON-STIMULATING MONOCLONAL ANTIBODY THT SPARES GAMMA DELTA T-CELLS AND TREATS AND PREVENTS CELLULAR REJECTION.: 1954

M. Siemionow, Stephen P. A. Brown, T. Waid, 2008 .

Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials

P. Butow, M. Jefford, M. Tattersall, 2017, BMJ Open.

Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module

A. Bottomley, M. King, L. V. van de Poll-Franse, 2015, Melanoma research.

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma

R. Scolyer, R. Kefford, G. Long, 2019, Cancers.

Genomic Landscape of Patient-matched Tumor and Circulating Cell-free DNA in Metastatic Melanoma

R. Scolyer, R. Kefford, G. Long, 2019 .

The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model

R. Saw, F. Boyle, J. Winstanley, 2013, Melanoma research.

Epigenetic profiling for the molecular classification of metastatic brain tumors

I. Shmulevich, T. Knijnenburg, C. Cobbs, 2018, bioRxiv.

Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine

J. Wilmott, R. Scolyer, R. Kefford, 2012, Molecular Cancer Therapeutics.

Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma

R. Scolyer, L. Haydu, J. Bonenkamp, 2012, Annals of surgery.

Germline variants are associated with increased primary melanoma tumor thickness at diagnosis

J. Barrett, M. Iles, D. Duffy, 2020, Human molecular genetics.

When is surgery for metastatic melanoma still the most appropriate treatment option?

P. Ferguson, E. Friedman, J. Thompson, 2018, Expert review of anticancer therapy.

The advantage of using a synoptic pathology report format for cutaneous melanoma

R. Scolyer, J. Thompson, K. S. van den Berg, 2007, Histopathology.

Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis.

D. Elder, R. Scolyer, S. McCarthy, 2006, The Australasian journal of dermatology.

Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients

Richard A. Scolyer, R. Scolyer, John F. Thompson, 2005 .

Diagnosis and management of cutaneous melanoma.

H. Soyer, John F. Thompson, M. Henderson, 2020, Australian journal of general practice.

Multidisciplinary care of cancer patients: a passing fad or here to stay?

John F. Thompson, Gabrielle J. Williams, J. Thompson, 2019, ANZ journal of surgery.

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins

R. Scolyer, P. Hersey, Xu Dong Zhang, 2010, Modern Pathology.

Primary dermal melanoma: clinical behaviour, prognosis and treatment.

K. Shannon, R. Scolyer, R. Karim, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

J. Wilmott, R. Scolyer, G. Long, 2019, Clinical Cancer Research.

INTESTINAL TRANSPLANTATION FOR SHORT GUT SYNDROME SECONDARY TO GASTROSCHISIS

G. Selvaggi, S. Nishida, J. Madariaga, 2004 .

RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes

G. Mann, J. Wilmott, R. Scolyer, 2019, International journal of cancer.

Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma.

R. Scolyer, S. McCarthy, G. Watson, 2017, Pathology.

Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.

K. Shannon, R. Scolyer, L. Haydu, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Normal Growth and Essential Fatty Acid Status in Children With Intestinal Failure on Lipid Limitation

J. Thompson, Irina G. Strogach, G. Lam, 2016, Journal of pediatric gastroenterology and nutrition.

Intrapatient Homogeneity of BRAFV600E Expression in Melanoma

J. Wilmott, R. Scolyer, S. O'toole, 2014, The American journal of surgical pathology.

Groin and pelvic dissection for melanoma

C. Karakousis, J. Thompson, 2003 .

What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire

F. Boyle, J. Winstanley, J. Thompson, 2013, Melanoma research.

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers

James X. Sun, Lesly A. Dossett, V. Sondak, 2022, Annals of surgery.

Competing risks analysis with missing cause-of-failure—penalized likelihood estimation of cause-specific Cox models

R. Scolyer, Jun Ma, M. Manuguerra, 2022, Statistical methods in medical research.

LETTERS TO THE EDITOR

D. Elder, R. Scolyer, S. McCarthy, 2006 .

Management of pigmented skin lesions during pregnancy.

R. Scolyer, E. Friedman, J. Thompson, 2019, Australian journal of general practice.

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas

K. Shannon, G. Mann, N. Hayward, 2019, Oncotarget.

Sentinel Lymph Node Biopsy: Evolution of the Technique Since the Original Description by Morton et al. in 1992.

O. Nieweg, R. Uren, J. Thompson, 2016, Critical reviews in oncogenesis.

Necrotizing fasciitis following liver and small intestine transplantation

Shogo Kobayashi, S. Nishida, A. Tzakis, 2002, Pediatric transplantation.

Primary care support for tackling obesity

A. Tod, I. Brown, Joanne Thompson, 2006 .

Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study

F. Rapport, A. Cust, H. Schmid, 2020, The Australasian journal of dermatology.

Regarding complications following completion lymphadenectomy.

A. Cochran, M. Faries, J. Thompson, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Textbook of Melanoma : Pathology, Diagnosis and Management

D. Morton, B. Kroon, J. Thompson, 2003 .

Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases

K. Shannon, R. Scolyer, T. Ahmed, 2022, Annals of Surgical Oncology.

Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data be Heard

A. Cochran, M. Faries, J. Thompson, 2014, Annals of Surgical Oncology.

Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy

R. Fisher, H. Hoekstra, A. Hong, 2009 .

Unintentional 4-Aminopyridine Overdose in a Multiple Sclerosis Patient

J. Thompson, 2013 .

MP14-08 A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (mRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN)

S. Psutka, E. Gross, J. Kramer, 2021 .

Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?

C. O'brien, M. Quinn, W. McCarthy, 2001, Head & neck.

ASO Author Reflections: Surgical Resection May Improve the Outcome for Patients with Residual Metastatic Melanoma When Modern Systemic Therapies Have Not Achieved Complete Disease Control

R. Scolyer, S. Ch’ng, J. Thompson, 2021, Annals of Surgical Oncology.

Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience

R. Saw, Jin-soo Park, C. Young, 2018, Annals of surgical oncology.

Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice

S. Lo, A. Hong, G. Fogarty, 2016, BMC Cancer.

Quality of Life Following Surgical Excision of Early-Stage Melanoma of the Head and Neck.

R. Scolyer, S. Lo, J. Thompson, 2019, JAMA dermatology.

Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies

S. Ourselin, R. Scolyer, R. Bourne, 2010, Melanoma research.

High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial

M. Atkins, E. Galanis, R. Gonzalez, 2005 .

3305 PD1 inhibition-induced changes in melanoma and its associated immune infiltrate

J. Madore, J. Wilmott, R. Scolyer, 2015 .

Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied-Reply.

R. Scolyer, M. El Sharouni, J. Thompson, 2021, JAMA dermatology.

Recombinant IL-21 in combination with sorafenib: Preliminary results from a phase I/II study in patients with metastatic renal cell cancer

D. Quinn, B. Curti, T. Devries, 2007 .

Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

K. Shannon, B. Armstrong, R. Saw, 2014, BMC Cancer.

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets

J. Pearson, K. Shannon, G. Mann, 2019, Nature Communications.

Staging and prognostic factors for stage IV melanoma: Initial results of an American Joint Committee on Cancer (AJCC) international evidence-based assessment of 4,895 melanoma patients

V. Sondak, J. Kirkwood, A. Eggermont, 2008 .

Lymphatic mapping and sentinel lymph node biopsy: the concept

J. Thompson, 2003 .

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis

G. Mann, N. Hayward, J. Wilmott, 2018, British Journal of Cancer.

Determining optimal sequencing of anti-PD-1 and BRAF-targeted therapy: A phase II randomised study of neoadjuvant pembrolizumab with/without dabrafenib and trametinib (D+T) in BRAF V600 mutant resectable stage IIIb/c/d melanoma (NeoTrio trial).

K. Shannon, R. Scolyer, G. Long, 2018 .

Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management.

G. Mann, G. Long, A. Varey, 2020, Australian Journal of General Practice.

Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients

R. Scolyer, R. Gutzmer, H. Shaw, 2007, Histopathology.

Genetic alterations and personalized medicine in melanoma: progress and future prospects.

D. Schadendorf, K. Flaherty, R. Scolyer, 2014, Journal of the National Cancer Institute.

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

G. Pupo, J. Wilmott, R. Scolyer, 2017, Clinical Cancer Research.

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

J. Madore, J. Wilmott, R. Scolyer, 2017, Clinical Cancer Research.

Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes

R. Scolyer, S. Mocellin, J. Stretch, 2013, Pigment cell & melanoma research.

Ultrasound assessment of lymph nodes in the management of early‐stage melanoma

L. Haydu, R. Uren, J. Thompson, 2011, Journal of surgical oncology.

DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.

J. Wilmott, R. Scolyer, D. Morton, 2014, Neuro-oncology.

Letter to the Editor

R. Uren, R. Howman-Giles, J. Thompson, 2000 .

SURGICAL PROCEDURES FOR MELANOMA IN PUBLIC AND PRIVATE NEW SOUTH WALES HOSPITALS, 2001–2002

M. Frommer, M. Barton, P. E. Holt, 2006, ANZ journal of surgery.

Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA–D Melanoma

A. Einstein, R. Turner, R. Saw, 2021, Annals of Surgical Oncology.

Primary oesophageal melanoma - a case report

R. Scolyer, D. Damian, J. Thompson, 2014, World Journal of Surgical Oncology.

ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges

A. Chakera, J. Thompson, 2019, Annals of Surgical Oncology.

The value of sentinel node biopsy in patients with primary cutaneous melanoma.

J. Thompson, 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Radiofrequency ablation in metastatic melanoma

A. Shashank, D. Morris, M. Shehata, 2014, Journal of surgical oncology.

Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis

O. Nieweg, R. Uren, J. Thompson, 2019, Annals of Surgical Oncology.

The Challenge of Defining Guidelines for Sentinel Lymph Node Biopsy in Patients with Thin Primary Cutaneous Melanomas

V. Sondak, J. Gershenwald, D. Coit, 2012, Annals of Surgical Oncology.

Australian Multicenter Study of Isolated Limb Infusion for Melanoma

B. Coventry, A. Barbour, M. Henderson, 2016, Annals of Surgical Oncology.

Neoadjuvant dabrafenib and trametinib (D+T) for stage III melanoma: Long-term results from the NeoCombi trial.

K. Shannon, R. Scolyer, G. Long, 2022, Journal of Clinical Oncology.

Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma

M. Ross, K. Shannon, J. Wargo, 2015 .

Factors Predictive of Acute Regional Toxicity After Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma Patients

P. Kam, M. Moncrieff, H. Kroon, 2009, Annals of Surgical Oncology.

Current status of isolated limb infusion with mild hyperthermia for melanoma

P. Kam, J. Thompson, 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

An Integrated Tree-Based Classification Approach to Prognostic Grouping with Application to Localized Melanoma Patients

Seng-Jaw Soong, Chen-An Tsai, Dung-Tsa Chen, 2007, Journal of biopharmaceutical statistics.

Comprehensive molecular profiling of metastatic melanoma to predict response to monotherapy and combination immunotherapy.

K. Shannon, G. Mann, N. Hayward, 2019, Journal of Clinical Oncology.